These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34458008)

  • 21. Twin Prime Editing Mediated Exon Skipping/Reinsertion for Restored Collagen VII Expression in Recessive Dystrophic Epidermolysis Bullosa.
    Steinbeck BJ; Gao XD; McElroy AN; Pandey S; Doman JL; Riddle MJ; Xia L; Chen W; Eide CR; Lengert AH; Han SW; Blazar BR; Wandall HH; Dabelsteen S; Liu DR; Tolar J; Osborn MJ
    J Invest Dermatol; 2024 May; ():. PubMed ID: 38763174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TALEN-based gene correction for epidermolysis bullosa.
    Osborn MJ; Starker CG; McElroy AN; Webber BR; Riddle MJ; Xia L; DeFeo AP; Gabriel R; Schmidt M; von Kalle C; Carlson DF; Maeder ML; Joung JK; Wagner JE; Voytas DF; Blazar BR; Tolar J
    Mol Ther; 2013 Jun; 21(6):1151-9. PubMed ID: 23546300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients.
    Ryoo YW; Kim BC; Lee KS
    J Dermatol Sci; 2001 Jun; 26(2):125-32. PubMed ID: 11378329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases.
    Kocher T; Peking P; Klausegger A; Murauer EM; Hofbauer JP; Wally V; Lettner T; Hainzl S; Ablinger M; Bauer JW; Reichelt J; Koller U
    Mol Ther; 2017 Nov; 25(11):2585-2598. PubMed ID: 28888469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5'RNA
    Mayr E; Ablinger M; Lettner T; Murauer EM; Guttmann-Gruber C; Piñón Hofbauer J; Hainzl S; Kaiser M; Klausegger A; Bauer JW; Koller U; Wally V
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells.
    Mencía Á; Chamorro C; Bonafont J; Duarte B; Holguin A; Illera N; Llames SG; Escámez MJ; Hausser I; Del Río M; Larcher F; Murillas R
    Mol Ther Nucleic Acids; 2018 Jun; 11():68-78. PubMed ID: 29858091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
    Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
    J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9.
    Takashima S; Shinkuma S; Fujita Y; Nomura T; Ujiie H; Natsuga K; Iwata H; Nakamura H; Vorobyev A; Abe R; Shimizu H
    J Invest Dermatol; 2019 Aug; 139(8):1711-1721.e4. PubMed ID: 30831133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On- and off-target effects of paired CRISPR-Cas nickase in primary human cells.
    Klermund J; Rhiel M; Kocher T; Chmielewski KO; Bischof J; Andrieux G; El Gaz M; Hainzl S; Boerries M; Cornu TI; Koller U; Cathomen T
    Mol Ther; 2024 May; 32(5):1298-1310. PubMed ID: 38459694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes.
    Latella MC; Cocchiarella F; De Rosa L; Turchiano G; Gonçalves MAFV; Larcher F; De Luca M; Recchia A
    J Invest Dermatol; 2017 Apr; 137(4):836-844. PubMed ID: 28027893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo.
    Chamorro C; Almarza D; Duarte B; Llames SG; Murillas R; García M; Cigudosa JC; Espinosa-Hevia L; Escámez MJ; Mencía A; Meana A; García-Escudero R; Moro R; Conti CJ; Del Río M; Larcher F
    Exp Dermatol; 2013 Sep; 22(9):601-3. PubMed ID: 23947675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa.
    Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW
    J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
    Condorelli AG; Logli E; Cianfarani F; Teson M; Diociaiuti A; El Hachem M; Zambruno G; Castiglia D; Odorisio T
    Br J Dermatol; 2019 Nov; 181(5):1017-1027. PubMed ID: 30816994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa.
    Atanasova VS; Jiang Q; Prisco M; Gruber C; Piñón Hofbauer J; Chen M; Has C; Bruckner-Tuderman L; McGrath JA; Uitto J; South AP
    J Invest Dermatol; 2017 Sep; 137(9):1842-1849. PubMed ID: 28549954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
    Perdoni C; Osborn MJ; Tolar J
    Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico.
    Saeidian AH; Youssefian L; Moreno Trevino MG; Fortuna G; Vahidnezhad H; Atanasova VS; Uitto J; Salas-Alanis JC; South AP
    Clin Exp Dermatol; 2018 Jul; 43(5):579-584. PubMed ID: 29473190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
    J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA-based prenatal diagnosis of generalized recessive dystrophic epidermolysis bullosa in six pregnancies at risk for recurrence.
    Hovnanian A; Hilal L; Blanchet-Bardon C; Bodemer C; de Prost Y; Stark CA; Christiano AM; Dommergues M; Terwilliger JD; Izquierdo L
    J Invest Dermatol; 1995 Apr; 104(4):456-61. PubMed ID: 7706758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
    Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
    Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.